Clinical trial NCT02592824 - References

Heart Failure — Glutamate for Metabolic Intervention in Coronary Surgery II

Citation(s)

•   Aya HD, Cecconi M, Hamilton M, Rhodes A
  Goal-directed therapy in cardiac surgery: a systematic review and meta-analysis. Br J Anaesth. 2013 Apr;110(4):510-7. doi: 10.1093/bja/aet020. Epub 2013 Feb 27.
•   Dahlin LG, Olin C, Svedjeholm R
  Perioperative myocardial infarction in cardiac surgery--risk factors and consequences. A case control study. Scand Cardiovasc J. 2000 Oct;34(5):522-7. doi: 10.1080/140174300750064710.
•   de Lemos JA, McGuire DK, Drazner MH
  B-type natriuretic peptide in cardiovascular disease. Lancet. 2003 Jul 26;362(9380):316-22. doi: 10.1016/S0140-6736(03)13976-1.
•   Engelman RM, Rousou JA, Flack JE 3rd, Iyengar J, Kimura Y, Das DK
  Reduction of infarct size by systemic amino acid supplementation during reperfusion. J Thorac Cardiovasc Surg. 1991 May;101(5):855-9.
•   Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A
  Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology. 2008 Jun;108(6):979-87. doi: 10.1097/ALN.0b013e318173026f.
•   Fox AA, Nascimben L, Body SC, Collard CD, Mitani AA, Liu KY, Muehlschlegel JD, Shernan SK, Marcantonio ER
  Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery. Anesthesiology. 2013 Aug;119(2):284-94. doi: 10.1097/ALN.0b013e318299969c.
•   Giglio M, Dalfino L, Puntillo F, Rubino G, Marucci M, Brienza N
  Haemodynamic goal-directed therapy in cardiac and vascular surgery. A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2012 Nov;15(5):878-87. doi: 10.1093/icvts/ivs323. Epub 2012 Jul 24.
•   Gillies M, Bellomo R, Doolan L, Buxton B
  Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery -- a systematic literature review. Crit Care. 2005 Jun;9(3):266-79. doi: 10.1186/cc3024. Epub 2004 Dec 16.
•   Haas GS, DeBoer LW, O'Keefe DD, Bodenhamer RM, Geffin GA, Drop LJ, Teplick RS, Daggett WM
  Reduction of postischemic myocardial dysfunction by substrate repletion during reperfusion. Circulation. 1984 Sep;70(3 Pt 2):I65-74.
•   Karlstrom P, Alehagen U, Boman K, Dahlstrom U; UPSTEP-study group
  Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome. Eur J Heart Fail. 2011 Oct;13(10):1096-103. doi: 10.1093/eurjhf/hfr078. Epub 2011 Jun 29. Erratum In: Eur J Heart Fail. 2012 May;14(5):563. von den Luederer Tomas [corrected to von Lueder, Thomas G].
•   Khoynezhad A, Jalali Z, Tortolani AJ
  Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon. Ann Thorac Surg. 2004 Sep;78(3):1109-18. doi: 10.1016/j.athoracsur.2003.06.034.
•   Lazar HL, Buckberg GD, Foglia RP, Manganaro AJ, Maloney JV Jr
  Detrimental effects of premature use of inotropic drugs to discontinue cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981 Jul;82(1):18-25.
•   Lazar HL, Buckberg GD, Manganaro AJ, Becker H, Maloney JV Jr
  Reversal of ischemic damage with amino acid substrate enhancement during reperfusion. Surgery. 1980 Nov;88(5):702-9.
•   Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, Braunwald E
  Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971 Jan;43(1):67-82. doi: 10.1161/01.cir.43.1.67. No abstract available.
•   Mebazaa A, Pitsis AA, Rudiger A, Toller W, Longrois D, Ricksten SE, Bobek I, De Hert S, Wieselthaler G, Schirmer U, von Segesser LK, Sander M, Poldermans D, Ranucci M, Karpati PC, Wouters P, Seeberger M, Schmid ER, Weder W, Follath F
  Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care. 2010;14(2):201. doi: 10.1186/cc8153. Epub 2010 Apr 28.
•   Nozohoor S, Nilsson J, Algotsson L, Sjogren J
  Postoperative increase in B-type natriuretic peptide levels predicts adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth. 2011 Jun;25(3):469-75. doi: 10.1053/j.jvca.2010.07.002. Epub 2010 Sep 9.
•   O'Connor GT, Birkmeyer JD, Dacey LJ, Quinton HB, Marrin CA, Birkmeyer NJ, Morton JR, Leavitt BJ, Maloney CT, Hernandez F, Clough RA, Nugent WC, Olmstead EM, Charlesworth DC, Plume SK
  Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 1998 Oct;66(4):1323-8. doi: 10.1016/s0003-4975(98)00762-0.
•   Peuhkurinen KJ
  Regulation of the tricarboxylic acid cycle pool size in heart muscle. J Mol Cell Cardiol. 1984 Jun;16(6):487-95. doi: 10.1016/s0022-2828(84)80637-9.
•   Pisarenko OI, Lepilin MG, Ivanov VE
  Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure. Clin Sci (Lond). 1986 Jan;70(1):7-12. doi: 10.1042/cs0700007.
•   Pisarenko OI, Novikova EB, Serebryakova LI, Tskitishvili OV, Ivanov VE, Studneva IM
  Function and metabolism of dog heart in ischemia and in subsequent reperfusion: effect of exogenous glutamic acid. Pflugers Arch. 1985 Dec;405(4):377-83. doi: 10.1007/BF00595691.
•   Pisarenko OI
  Mechanisms of myocardial protection by amino acids: facts and hypotheses. Clin Exp Pharmacol Physiol. 1996 Aug;23(8):627-33. doi: 10.1111/j.1440-1681.1996.tb01748.x.
•   Rau EE, Shine KI, Gervais A, Douglas AM, Amos EC 3rd
  Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion. Am J Physiol. 1979 Jun;236(6):H873-9. doi: 10.1152/ajpheart.1979.236.6.H873. No abstract available.
•   Reyes G, Fores G, Rodriguez-Abella RH, Cuerpo G, Vallejo JL, Romero C, Pinto A
  NT-proBNP in cardiac surgery: a new tool for the management of our patients? Interact Cardiovasc Thorac Surg. 2005 Jun;4(3):242-7. doi: 10.1510/icvts.2004.101576. Epub 2005 Mar 30.
•   Safer B
  The Metabolic Significance of the Malate-Aspartate Cycle in Heart. Circ Res. 1975 Nov;37(5):527-33. doi: 10.1161/01.res.37.5.527. No abstract available.
•   Shahin J, DeVarennes B, Tse CW, Amarica DA, Dial S
  The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care. 2011 Jul 7;15(4):R162. doi: 10.1186/cc10302.
•   Slogoff S, Keats AS
  Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology. 1985 Feb;62(2):107-14. doi: 10.1097/00000542-198502000-00002.
•   Svedjeholm R, Huljebrant I, Hakanson E, Vanhanen I
  Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations. Ann Thorac Surg. 1995 Feb;59(2 Suppl):S23-30. doi: 10.1016/0003-4975(94)00918-w.
•   Svedjeholm R, Vanhanen I, Hakanson E, Joachimsson PO, Jorfeldt L, Nilsson L
  Metabolic and hemodynamic effects of intravenous glutamate infusion early after coronary operations. J Thorac Cardiovasc Surg. 1996 Dec;112(6):1468-77. doi: 10.1016/S0022-5223(96)70005-3.
•   Svedjeholm R, Vidlund M, Vanhanen I, Hakanson E
  A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG. Scand Cardiovasc J. 2010 Feb;44(1):45-58. doi: 10.3109/14017430903531008.
•   Thackray S, Easthaugh J, Freemantle N, Cleland JG
  The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail. 2002 Aug;4(4):515-29. doi: 10.1016/s1388-9842(02)00041-7.
•   Vanky F, Hakanson E, Maros T, Svedjeholm R
  Different characteristics of postoperative heart failure after surgery for aortic stenosis and coronary disease. Scand Cardiovasc J. 2004 Jun;38(3):152-8. doi: 10.1080/14017430410029734.
•   Vanky FB, Hakanson E, Svedjeholm R
  Long-term consequences of postoperative heart failure after surgery for aortic stenosis compared with coronary surgery. Ann Thorac Surg. 2007 Jun;83(6):2036-43. doi: 10.1016/j.athoracsur.2007.01.031.
•   Vidlund M, Hakanson E, Friberg O, Juhl-Andersen S, Holm J, Vanky F, Sunnermalm L, Borg JO, Sharma R, Svedjeholm R
  GLUTAMICS--a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome. J Thorac Cardiovasc Surg. 2012 Oct;144(4):922-930.e7. doi: 10.1016/j.jtcvs.2012.05.066. Epub 2012 Jun 19.

Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II

Details for clinical trial NCT02592824